1,722,138 research outputs found
Reply to Emily Vertosick and Andrew Vickers' Letter to the Editor re: Alberto Briganti, Thomas Wiegel, Steven Joniau, et al. Early Salvage Radiation Therapy Does Not Compromise Cancer Control in Patients with pT3N0 Prostate Cancer after Radical Prostatectomy: Results of a Match-Controlled Multi-institutional Analysis. Eur Urol 2012;62:472-87
Reply to Tommaso Cai, Riccardo Bartoletti and Gabriella Nesi's Letter to the Editor re: Alberto Briganti, Umberto Capitanio, Felix K.-H. Chun et al. Impact of Surgical Volume on the Rate of Lymph Node Metastases in Patients Undergoing Radical Prostatectomy and Extended Pelvic Lymph Node Dissection for Clinically Localized Prostate Cancer
Case Presentation: A Man with Two Synchronous and Symptomatic Malignancies Related to Smoking
Editorial Comment to Nodal involvement at nephrectomy is associated with worse survival: A stage-for-stage and grade-for-grade analysis
Re: Surgical outcomes in the management of isolated nodal recurrences: A multicenter, international retrospective cohort
Reply from Authors re: Michel Bolla. Adjuvant or Immediate External Irradiation After Radical Prostatectomy with Pelvic Lymph Node Dissection for High-Risk Prostate Cancer: A Multidisciplinary Decision. Eur Urol 2013;63:1009-10
Reply to Chris Parker, Matthew R. Sydes and Howard Kynaston's Letter to the Editor re: Firas Abdollah, Nazareno Suardi, Cesare Cozzarini, et al. Selecting the Optimal Candidate for Adjuvant Radiotherapy After Radical Prostatectomy for Prostate Cancer: A Long-term Survival Analysis. Eur Urol 2013;63:998-1008.
Re: Stephen H. Culp, Paul F. Schellhammer, Michael B. Williams. Might men diagnosed with metastatic prostate cancer benefit from definitive treatment of the primary tumor? A SEER-based study. Eur Urol 2014;65:1058–66
Re: Risk Group and Death From Prostate Cancer: Implications for Active Surveillance in Men with Favorable Intermediate-risk Prostate Cancer
- …
